Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.77 - $4.63 $2,493 - $4,167
900 Added 4.66%
20,200 $57,000
Q1 2024

May 14, 2024

BUY
$4.02 - $5.39 $77,585 - $104,027
19,300 New
19,300 $81,000
Q3 2022

Nov 14, 2022

SELL
$2.33 - $3.92 $69,900 - $117,600
-30,000 Reduced 74.44%
10,300 $26,000
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.42 $62,975 - $123,264
19,200 Added 91.0%
40,300 $145,000
Q1 2022

May 13, 2022

SELL
$5.16 - $7.14 $38,184 - $52,836
-7,400 Reduced 25.96%
21,100 $131,000
Q4 2021

Feb 11, 2022

BUY
$6.37 - $8.18 $91,091 - $116,974
14,300 Added 100.7%
28,500 $201,000
Q3 2021

Nov 12, 2021

BUY
$6.98 - $8.47 $99,116 - $120,274
14,200 New
14,200 $99,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $90.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.